{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:14:19Z","timestamp":1779358459791,"version":"3.51.4"},"reference-count":17,"publisher":"American Diabetes Association","issue":"3","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:p>OBJECTIVE\u2014To investigate the impact of a long-acting injectable progestin, depo-medroxyprogesterone acetate (DMPA), compared with combination oral contraceptives (COCs) on the risk of diabetes in Latino women with prior gestational diabetes mellitus (GDM).<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014An observational cohort study of 526 Hispanic women with prior GDM who were not diabetic in their postpartum visit during January 1987 to October 1997 and who elected DMPA (n = 96) or COCs (n = 430) as initial contraception were followed for a maximum of 9.2 years with a median follow-up of \u223c12 months. Oral glucose tolerance tests were performed and choice of contraception method was recorded at each visit as part of routine clinical care.<\/jats:p>\n               <jats:p>RESULTS\u2014Annual diabetes incidence rates were 19% in the DMPA group and 12% in the COC group, with an unadjusted hazard ratio (HR) of 1.58 (95% CI 1.00\u20132.50; P = 0.05) for DMPA compared with COCs. Adjustment for baseline imbalances reduced the HR to 1.18 (0.67\u20132.28; P = 0.57). Additional adjustment for weight gain during follow-up, which was on average 1.8 kg higher in the DMPA group (P &amp;lt; 0.0001), reduced the HR to 1.07. DMPA interacted with baseline serum triglyceride levels and, separately, with breast-feeding to increase the diabetes risk.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014DMPA use was associated with an increased risk of diabetes that appeared to be explained by three factors: 1) use in women with increased baseline diabetes risk, 2) weight gain during use, and 3) use with high baseline triglycerides and\/or during breast-feeding.<\/jats:p>","DOI":"10.2337\/diacare.29.03.06.dc05-1940","type":"journal-article","created":{"date-parts":[[2006,5,10]],"date-time":"2006-05-10T22:42:10Z","timestamp":1147300930000},"page":"613-617","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":72,"title":["Long-Acting Injectable Progestin Contraception and Risk of Type 2 Diabetes in Latino Women With Prior Gestational Diabetes Mellitus"],"prefix":"10.2337","volume":"29","author":[{"given":"Anny H.","family":"Xiang","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Kawakubo","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri L.","family":"Kjos","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, California"},{"name":"Department of Obstetrics and Gynecology, Harbor UCLA Medical Center, Torrance, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Buchanan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, California"},{"name":"Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031217081273300_R1","doi-asserted-by":"crossref","unstructured":"Kjos SL, Peters RK, Xiang AH, Henry OA, Montoro MN, Buchanan TA: Predicting future diabetes in Latino women with gestational diabetes: utility of early postpartum glucose tolerance testing. Diabetes\u200844: 586\u2013591, 1995","DOI":"10.2337\/diab.44.5.586"},{"key":"2022031217081273300_R2","doi-asserted-by":"crossref","unstructured":"Buchanan TA, Xiang AH, Kjos SL, Lee WP, Trigo E, Nader I, Bergner A, Palmer JL, Peters RK: Gestational diabetes mellitus: antepartum metabolic characteristics that predict postpartum glucose intolerance and type 2 diabetes. Diabetes\u200847: 1302\u20131310, 1998","DOI":"10.2337\/diab.47.8.1302"},{"key":"2022031217081273300_R3","doi-asserted-by":"crossref","unstructured":"Buchanan TA, Xiang AH, Kjos SL, Trigo E, Lee WP, Peters RK: Antepartum predictors of the development of type 2 diabetes in latino women 11\u201326 months after pregnancies complicated by gestational diabetes. Diabetes\u200848: 2430\u20132436, 1999","DOI":"10.2337\/diabetes.48.12.2430"},{"key":"2022031217081273300_R4","doi-asserted-by":"crossref","unstructured":"Kjos S, Peters R, Xiang A, Thomas D, Schafer U, Ta B: Oral contraception and the risk of type 2 diabetes in Latino women with prior gestational diabetes. J Am Med Assoc\u2008280: 533\u2013538, 1998","DOI":"10.1001\/jama.280.6.533"},{"key":"2022031217081273300_R5","doi-asserted-by":"crossref","unstructured":"Peters RK, Kjos SL, Xiang AH, Buchanan TA: Long-term diabetogenic effect of a single pregnancy in women with prior gestational diabetes mellitus. Lancet\u2008347: 227\u2013230, 1996","DOI":"10.1016\/S0140-6736(96)90405-5"},{"key":"2022031217081273300_R6","doi-asserted-by":"crossref","unstructured":"Schafer UM, Songster G, Xiang AH, Berkowitz K, Buchanan TA, Kjos SL: Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstet Gynecol\u2008177: 1165\u20131171, 1997","DOI":"10.1016\/S0002-9378(97)70035-8"},{"key":"2022031217081273300_R7","doi-asserted-by":"crossref","unstructured":"Spellacy WN: Metabolic effects of oral contraceptives. Clin Obstet Gynecol\u200817: 53\u201364, 1974","DOI":"10.1097\/00003081-197403000-00008"},{"key":"2022031217081273300_R8","doi-asserted-by":"crossref","unstructured":"Rimm EB, Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Hennekens CH, Speizer FE: Oral contraceptive use and the risk of type 2 diabetes mellitus in a large prospective study of women. Diabetologia\u200835: 967\u2013972, 1992","DOI":"10.1007\/BF00401427"},{"key":"2022031217081273300_R9","doi-asserted-by":"crossref","unstructured":"Liew DF, Ng CS, Yong YM, Ratnam SS: Long term effects of depo-provera on carbohydrate and lipid metabolism. Contraception\u200831: 51\u201364, 1985","DOI":"10.1016\/0010-7824(85)90074-5"},{"key":"2022031217081273300_R10","doi-asserted-by":"crossref","unstructured":"Fahmy K, Abdel-Razik M, Shaaraway M, al-Kholy G, Saad S, Wagdi A, al-Azzony M: Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile. Contraception\u200844: 419\u2013430, 1991","DOI":"10.1016\/0010-7824(91)90032-B"},{"key":"2022031217081273300_R11","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA\u2008269: 3015\u20133023, 1993","DOI":"10.1001\/jama.269.23.3015"},{"key":"2022031217081273300_R12","doi-asserted-by":"crossref","unstructured":"American Diabetes Association: Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care\u200827(Suppl. 1): S5\u2013S10, 2004","DOI":"10.2337\/diacare.27.2007.S5"},{"key":"2022031217081273300_R13","doi-asserted-by":"crossref","unstructured":"Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES: Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes\u200854: 1195\u20131200, 2004","DOI":"10.2337\/diabetes.53.5.1195"},{"key":"2022031217081273300_R14","doi-asserted-by":"crossref","unstructured":"Abbasi F, McLaughlin T, Lamendola C, H. Y-K, Tanaka A, Wang T, Nakajima K, Reaven GM: Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers. J Clin Endocrinol Metab\u200884: 3903\u20133906, 1999","DOI":"10.1210\/jc.84.11.3903"},{"key":"2022031217081273300_R15","doi-asserted-by":"crossref","unstructured":"Kim C, Seidel K, Begier E, Kwok Y: Diabetes and depot medroxyprogesterone contraception in Navajo women. Arch Intern Med\u2008161: 1766\u20131771, 2001","DOI":"10.1001\/archinte.161.14.1766"},{"key":"2022031217081273300_R16","doi-asserted-by":"crossref","unstructured":"Espey E, Steinhart J, Ogburn T, Qualls C: Depo-provera associaetd with weight gain in Navajo women. Contraception\u200862: 55\u201358, 2000","DOI":"10.1016\/S0010-7824(00)00144-X"},{"key":"2022031217081273300_R17","doi-asserted-by":"crossref","unstructured":"Oettel M, Mukhopadhyay A: Progesterone: the forgotten hormone in men? Aging Male\u20087: 236\u2013257, 2004","DOI":"10.1080\/13685530400004199"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/29\/3\/613\/593932\/zdc00306000613.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/29\/3\/613\/593932\/zdc00306000613.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T17:50:11Z","timestamp":1647107411000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/29\/3\/613\/25366\/Long-Acting-Injectable-Progestin-Contraception-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.29.03.06.dc05-1940","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}